MARKET

NRBO

NRBO

Neurobo Pharmaceuticals Inc
NASDAQ
0.8150
-0.0125
-1.51%
Opening 09:30 02/07 EST
OPEN
0.8150
PREV CLOSE
0.8275
HIGH
0.8150
LOW
0.8150
VOLUME
71.29K
TURNOVER
28.18K
52 WEEK HIGH
63.85
52 WEEK LOW
0.5510
MARKET CAP
15.46M
P/E (TTM)
-0.0521
1D
5D
1M
3M
1Y
5Y
Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
Benzinga · 01/24 13:04
BRIEF-Neurobo Pharmaceuticals Appoints Joseph Hooker As Interim CEO, President
Reuters · 01/18 15:24
NeuroBo appoints Joseph Hooker as Interim CEO
Seeking Alpha · 01/18 13:18
NeuroBo Pharmaceuticals Names Joseph Hooker Interim Chief Executive
NeuroBo Pharmaceuticals Names Joseph Hooker Interim Chief Executive
MT Newswires · 01/18 09:11
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
Benzinga · 01/03 12:55
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 12/26/2022 17:32
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 12/26/2022 13:07
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Benzinga · 12/23/2022 18:24
More
About NRBO
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies. The Company is engaged in providing therapeutic programs designed to impact a range of indications in coronavirus, neurodegenerative and cardiometabolic disease. Its products include ANA001, Niclosamide, NB-01 and NB-02. The ANA001 is an oral niclosamide formulation and is being developed as a treatment for patients with moderate coronavirus disease. Niclosamide is a potential oral antiviral and anti-inflammatory agent and being studied in a 60-subject Phase II clinical trial conducted in the United States. NB-01 primarily focused on the development of a treatment for painful diabetic neuropathy (PDN). NB-02 has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of a protein called tau, and with amyloid beta plaque deposition.

Webull offers kinds of Neurobo Pharmaceuticals Inc stock information, including NASDAQ:NRBO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRBO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NRBO stock methods without spending real money on the virtual paper trading platform.